Author

Y. Zurbuchen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 6

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 6 Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 4 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Assay:flow cytometry· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1

Frequent Co-Authors

C. Cervia· 6 shared O. Boyman· 6 shared J. Nilsson· 5 shared S. Adamo· 5 shared M. E. Raeber· 4 shared A. Rudiger· 3 shared L. C. Huber· 3 shared P. Taeschler· 3 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

6 shared papersImmunology

C. Cervia

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Fate and plasticity of SARS-CoV-2-specific B cells during memory and recall response in humans

Y. Zurbuchen, J. Michler, P. Taeschler, S. Adamo, C. Cervia, M. E. Raeber, I. E. Acar, J. Nilsson, M. B. Soyka, A. E. Moor, O. Boyman

The paper tracks SARS-CoV-2-specific memory B cell fate transitions in humans, showing single clones can adopt distinct functional trajectories during memory and recall responses.

bioRxiv · Oct 7, 2022 · PreprintImmunology

Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course

J. Muri, V. Cecchinato, A. Cavalli, A. A. Shanbhag, M. Matkovic, M. Biggiogero, P. A. Maida, J. Moritz, C. Toscano, E. Ghovehoud, R. Furlan, F. Barbic, A. Voza, G. De Nadai, C. Cervia, , Franzetti-Pelland

The paper finds that anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease outcomes and predict absence of long COVID symptoms.

bioRxiv · May 23, 2022 · PreprintImmunology

CD8+ T cell signature in acute SARS-CoV-2 infection identifies memory precursors

S. Adamo, J. Michler, Y. Zurbuchen, C. Cervia, P. Taeschler, M. E. Raeber, S. Baghai Sain, J. Nilsson, A. Moor, O. Boyman

The paper identifies a transcriptional signature in SARS-CoV-2-specific CD8+ T cells that distinguishes short-lived from long-lived memory cells one year post-infection.

bioRxiv · Jul 22, 2021Immunology

A distinct innate immune signature marks progression from mild to severe COVID-19

S. Chevrier, Y. Zurbuchen, C. Cervia, S. Adamo, M. E. Raeber, N. de Souza, S. Sivapatham, A. Jacobs, E. Bächli, A. Rudiger, M. Stüssi-Helbling, L. C. Huber, D. J. Schaer, J. Nilsson, O. Boyman, B. Bodenmiller

The paper identifies an innate immune signature associated with progression from mild to severe COVID-19 using mass cytometry and proteomics.

bioRxiv · Aug 4, 2020Immunology

Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19

S. Adamo, S. Chevrier, C. Cervia, Y. Zurbuchen, M. E. Räber, L. Yang, S. Sivapatham, A. Jacobs, E. Bächli, A. Rudiger, M. Stüssi-Helbling, L. C. Huber, D. Schaer, B. Bodenmiller, O. Boyman, J. Nilsson

This study identifies T cell apoptosis and migration as mechanisms of peripheral T cell lymphopenia in severe COVID-19 and links lymphopenia to subsequent T cell proliferation.

bioRxiv · Aug 4, 2020 · PreprintImmunology

Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19

C. Cervia, J. Nilsson, Y. Zurbuchen, A. Valaperti, J. Schreiner, A. Wolfensberger, M. E. Raeber, S. Adamo, M. Emmenegger, S. Hasler, P. P. Bosshard, E. De Cecco, E. Baechli, A. Rudiger, M. Stuessi-Helbling, , O. Boyman

This study compares SARS-CoV-2-specific antibody responses in mild and severe COVID-19 patients and healthcare workers, finding higher systemic IgA and IgG in severe cases and mucosal IgA in asymptomatic exposed individuals.

bioRxiv · May 21, 2020Immunology